The Effect of Crocus sativus L. and Its Constituents on Memory: Basic Studies and Clinical Applications

Memory-related disorders are a common public health issue. Memory impairment is frequent in degenerative diseases (such as Alzheimer's disease and Parkinson disease), cerebral injuries, and schizophrenia. The dried stigma of the plant Crocus sativus L. (C. sativus), commonly known as saffron, is used in folk medicine for various purposes. Several lines of evidence suggest that C. sativus and its constituents are implicated in cognition. Here we critically review advances in research of these emerging molecular targets for the treatment of memory disorders, and discuss their advantages over currently used cognitive enhancers as well remaining challenges. Current analysis has shown that C. sativus and its components might be a promising target for cognition impairments.

[1]  H. Saito,et al.  Effects of Crocus sativus L. on the ethanol-induced impairment of passive avoidance performances in mice. , 1994, Biological & pharmaceutical bulletin.

[2]  K. Panikkar,et al.  Antitumour activity of saffron (Crocus sativus). , 1991, Cancer letters.

[3]  M. Ansari,et al.  Effect of Saffron (Crocus sativus) on neurobehavioral and neurochemical changes in cerebral ischemia in rats. , 2006, Journal of medicinal food.

[4]  S. Akhondzadeh,et al.  Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders , 2007 .

[5]  S. Akhondzadeh,et al.  Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16‐week, randomized and placebo‐controlled trial , 2010, Journal of clinical pharmacy and therapeutics.

[6]  K. Panikkar,et al.  Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. , 1991, Nutrition and cancer.

[7]  M. Orkoula,et al.  Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  George Perry,et al.  Free radical damage, iron, and Alzheimer's disease , 1995, Journal of the Neurological Sciences.

[9]  H. Hosseinzadeh,et al.  Bioactivity assessment and toxicity of crocin: a comprehensive review. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[10]  S. Akhondzadeh,et al.  Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double‐blind randomized clinical trial , 2014, Human psychopharmacology.

[11]  H. Sadeghnia,et al.  Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[12]  Maria Tsachaki,et al.  Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection , 2011, Behavioural Brain Research.

[13]  M. Mansouri,et al.  Protective effects of crocin against cisplatin-induced acute renal failure and oxidative stress in rats. , 2008, Iranian biomedical journal.

[14]  M. Khalili,et al.  Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats. , 2010, Iranian biomedical journal.

[15]  M. Mansouri,et al.  Protective effects of oral crocin against intracerebroventricular streptozotocin-induced spatial memory deficit and oxidative stress in rats. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[16]  P. Tarantilis,et al.  Determination of saffron (Crocus sativus L.) components in crude plant extract using high-performance liquid chromatography-UV-visible photodiode-array detection-mass spectrometry. , 1995, Journal of chromatography. A.

[17]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[18]  R. Castellani,et al.  Alzheimer disease. , 2010, Disease-a-month : DM.

[19]  S. Akhondzadeh,et al.  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease , 2009, Psychopharmacology.

[20]  S. Gauthier,et al.  Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease , 2008, Canadian Medical Association Journal.

[21]  H. Hosseinzadeh,et al.  Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats , 2010, Phytotherapy research : PTR.

[22]  D. Kyriakidis,et al.  Croscus sativus-biological active constitutents , 2002 .

[23]  G. Litscher,et al.  Evidence-based Complementary and Alternative Medicine , 2006, Evidence-based Complementary and Alternative Medicine.

[24]  H. Sadeghnia,et al.  Effects of Saffron (Crocus sativus L.) and its Active Constituent, Crocin, on Recognition and Spatial Memory after Chronic Cerebral Hypoperfusion in Rats , 2012, Phytotherapy research : PTR.

[25]  Crocins, the active constituents of Crocus Sativus L., counteracted ketamine–induced behavioural deficits in rats , 2014, Psychopharmacology.

[26]  C. Olanow.  A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.

[27]  H. Sadeghnia,et al.  Effect of safranal on extracellular hippocampal levels of glutamate and aspartate during kainic Acid treatment in anesthetized rats. , 2008, Planta medica.

[28]  M. Manfait,et al.  Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. , 1994, Anticancer research.

[29]  J. J. Espinosa-Aguirre,et al.  Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. , 2004, Cancer detection and prevention.

[30]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[31]  M. Ansari,et al.  Neuroprotection by crocetin in a hemi-parkinsonian rat model , 2005, Pharmacology Biochemistry and Behavior.

[32]  H. Sadeghnia,et al.  Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[33]  G. Eisenbrand,et al.  Crocus sativus L. , 1992 .

[34]  M. Fatehi,et al.  Effects of Crocus sativus petals' extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. , 2003, Journal of ethnopharmacology.

[35]  Y. Shoyama,et al.  Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis , 2004, Neurochemistry International.

[36]  H. Hosseinzadeh,et al.  Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[37]  M. Polissiou,et al.  Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. , 2006, Journal of agricultural and food chemistry.

[38]  A. Hensel,et al.  Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices , 2011, Neuroscience.

[39]  M. Recio,et al.  An Update Review of Saffron and its Active Constituents , 1996 .

[40]  H. Hosseinzadeh,et al.  ANTIDEPRESSANT EFFECTS OF CROCUS SATIVUS STIGMA EXTRACTS AND ITS CONSTITUENTS, CROCIN AND SAFRANAL, IN MICE , 2004 .

[41]  H. Hosseinzadeh,et al.  Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice , 2009, Phytotherapy research : PTR.

[42]  D. Trafalis,et al.  Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies. , 2012, Journal of agricultural and food chemistry.

[43]  S. Akhondzadeh,et al.  Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study , 2013, Human psychopharmacology.

[44]  H. Hosseinzadeh,et al.  Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers , 2013, Iranian journal of basic medical sciences.

[45]  C. Forchetti.  Treating patients with moderate to severe Alzheimer's disease: implications of recent pharmacologic studies. , 2005, Primary care companion to the Journal of clinical psychiatry.

[46]  P. Tarantilis,et al.  Qualitative determination of volatile compounds and quantitative evaluation of safranal and 4-hydroxy-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde (HTCC) in Greek saffron. , 2004, Journal of agricultural and food chemistry.

[47]  Wen Na.  Effectiveness of crocin against myocardial injury , 2005 .

[48]  R. Reddy,et al.  Free radical pathology in schizophrenia: a review. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.

[49]  S. Akhondzadeh,et al.  Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. , 2005, Journal of ethnopharmacology.

[50]  Yong-qiu Zheng,et al.  Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia , 2007, Brain Research.

[51]  A. Bandegi,et al.  Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. , 2011, European journal of pharmacology.

[52]  Andrew Kertesz,et al.  Diagnosis and treatment of dementia: 2. Diagnosis , 2008, Canadian Medical Association Journal.

[53]  N. Nishiyama,et al.  Crocin Improves the Ethanol-induced Impairment of Learning Behaviors of Mice in Passive Avoidance Tasks , 1995 .

[54]  C. Wang,et al.  Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. , 1991, Carcinogenesis.

[55]  P. Tarantilis,et al.  Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[56]  S. Z. Bathaie,et al.  New Applications and Mechanisms of Action of Saffron and its Important Ingredients , 2010, Critical reviews in food science and nutrition.

[57]  J. Quevedo,et al.  Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[58]  P. Tarantilis,et al.  Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats’ memory , 2007, Behavioural Brain Research.

[59]  J. R. Jones,et al.  The use of crocetin in experimental atherosclerosis , 1975, Experientia.

[60]  H. Hosseinzadeh,et al.  ANTICONVULSANT EFFECTS OF AQUEOUS AND ETHANOLIC EXTRACTS OF CROCUS SATIVUS L. STIGMAS IN MICE , 2002 .

[61]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[62]  S. Akhondzadeh,et al.  Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] , 2004, BMC complementary and alternative medicine.

[63]  N. Pitsikas,et al.  Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat , 2006, Behavioural Brain Research.

[64]  P. Winterhalter,et al.  SAFFRON—RENEWED INTEREST IN AN ANCIENT SPICE , 2000 .

[65]  Atta-ur- Rahman,et al.  Studies in natural products chemistry , 1988 .

[66]  H. Hosseinzadeh,et al.  Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice , 2002, BMC pharmacology.

[67]  Ten years of cholinesterase inhibitors , 2009, International journal of geriatric psychiatry.

[68]  Y. Shoyama,et al.  Crocin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells. , 2001, Life sciences.

[69]  Fikart I. Abdullaev.  Cancer Chemopreventive and Tumoricidal Properties of Saffron (Crocus sativus L.) , 2002, Experimental biology and medicine.

[70]  S. Akhondzadeh,et al.  Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial , 2012, Psychopharmacology.

[71]  K. Abe,et al.  Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo. , 1994, The Journal of pharmacology and experimental therapeutics.

[72]  P. Tarantilis,et al.  Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive–compulsive disorder , 2012, Neuroscience Letters.

[73]  T. Woo,et al.  Oxidative stress in schizophrenia: An integrated approach , 2011, Neuroscience & Biobehavioral Reviews.